David O. Watson sold $523K of Apellis Pharmaceuticals (APLS)

Executed Sep 10 2025, disclosed Sep 12 2025, 2 days later.

Value, as filed

$523K

20,000 sh × $26.17

Executed

Sep 10 2025

the trade date, as filed

Disclosed

Sep 12 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DW David O. Watson General Counsel profile →

David O. Watson (General Counsel) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in APLS. The largest single filing was $171K of APLS (7,832 sh × $21.77, as filed), executed Jan 22.

The name

APLS APLS APLS · 32 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by David O. Watson in APLS

APLSSALE Apellis Pharmaceuticals, Inc. $171K
7,832 sh × $21.77
Exec Jan 22
Filed Jan 23 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. $128K
5,780 sh × $22.19
Exec Jan 13
Filed Jan 15 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. $122K
5,000 sh × $24.49
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. $100K
5,000 sh × $20.06
Exec Nov 17 2025
Filed Nov 18 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. $126K
5,000 sh × $25.22
Exec Oct 16 2025
Filed Oct 17 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. $122K
5,000 sh × $24.34
Exec Sep 16 2025
Filed Sep 18 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. $139K
5,000 sh × $27.80
Exec Aug 18 2025
Filed Aug 19 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. $140K
5,569 sh × $25.10
Exec Mar 5 2025
Filed Mar 6 2025 · 5:30 PM ET